A series of software malfunctions in locally manufactured MRI and CT diagnostic tools across several diagnostic chains in India in 2022 led to widespread misdiagnoses. This raised severe concerns among premium healthcare providers regarding the quality and reliability of domestic medical imaging systems, where software pipelines were often uncertified and patched together.
As a result of this quality crisis and a heightened emphasis on diagnostic accuracy, the market share of Swiss-engineered certified medical imaging software in Indian private diagnostic clinics jumped from 53% to 61% in 2023. Consequently, the licensing fees obtained by Swiss high-tech medical developers for export-grade enterprise software suites increased by 6%.
Another major catalyst for Swiss developers is the rapid growth of the affluent, health-conscious urban middle class in emerging South Asian economies. As household wealth increases in urban centres across India, patients are increasingly willing to pay a premium out-of-pocket for highly accurate, certified diagnostic procedures. Swiss software certifications are globally recognized as the gold standard for clinical precision and safety. Large Indian healthcare conglomerates are now negotiating directly with Swiss software developers to secure exclusive, multi-year licensing and support agreements.
Explain two likely impacts on high-precision medical software developers in Switzerland of the growth in the urban middle class in emerging markets such as India.
